SiNtx Technologies Inc

SiNtx insider buying signals confidence as the company pushes its silicon‑nitride orthopedic platform through Phase II trials and FDA clearance, offering safer, infection‑resistant implants.

Insider buying spurs optimism for SiNtx Technologies’ silicon‑nitride orthopedic platform, but investors must weigh its negative earnings and market decline.